DrugsControl Media Services
DrugsControl.org

News Detail

No survival benefit of two antiviral drugs in elderly COVID patients: Study (13-02-2024)

Beijing, 13 Feb 2024: An observational study in eClinicalMe......
View Details

Source : CIDRAP - University of Minnesota
eClinicalMedicine observational study antiviral drugs azvudine and nirmatrelvir/ritonavir (Paxlovid) ineffective in preventing death in elderly patients hospitalized for COVID-19 in China

Related News